Fund profile
Tickers
HIAHX, HBGHX
Fund manager
Total assets
$139.47 mm
Liabilities
$771.80 k
Net assets
$138.70 mm
Number of holdings
103.00
103 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 12.45 mm | 21.35 k shares | 8.97 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 10.67 mm | 20.27 k shares | 7.69 | Common equity | Long | USA |
MRK Merck & Co Inc | 8.05 mm | 73.79 k shares | 5.80 | Common equity | Long | USA |
DHR Danaher Corp. | 5.25 mm | 22.69 k shares | 3.79 | Common equity | Long | USA |
PFE Pfizer Inc. | 4.20 mm | 145.96 k shares | 3.03 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 3.60 mm | 62.36 k shares | 2.60 | Common equity | Long | USA |
SYK Stryker Corp. | 3.58 mm | 11.95 k shares | 2.58 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 3.53 mm | 8.68 k shares | 2.55 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 3.33 mm | 16.85 k shares | 2.40 | Common equity | Long | USA |
HCA HCA Healthcare Inc | 3.27 mm | 12.08 k shares | 2.36 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 3.25 mm | 6.13 k shares | 2.34 | Common equity | Long | USA |
CNC Centene Corp. | 3.15 mm | 42.42 k shares | 2.27 | Common equity | Long | USA |
HUM Humana Inc. | 3.15 mm | 6.87 k shares | 2.27 | Common equity | Long | USA |
AstraZeneca PLC
|
2.60 mm | 38.62 k shares | 1.88 | Common equity | Long | UK |
COR Cencora Inc. | 2.51 mm | 12.23 k shares | 1.81 | Common equity | Long | USA |
ABT Abbott Laboratories | 2.42 mm | 22.02 k shares | 1.75 | Common equity | Long | USA |
MOH Molina Healthcare Inc | 2.34 mm | 6.49 k shares | 1.69 | Common equity | Long | USA |
DXCM Dexcom Inc | 2.32 mm | 18.67 k shares | 1.67 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 2.31 mm | 30.31 k shares | 1.67 | Common equity | Long | USA |
A Agilent Technologies Inc. | 2.20 mm | 15.83 k shares | 1.59 | Common equity | Long | USA |
ICON PLC
|
2.00 mm | 7.08 k shares | 1.45 | Common equity | Long | Ireland |
Daiichi Sankyo Co Ltd
|
1.68 mm | 61.34 k shares | 1.21 | Common equity | Long | Japan |
BIIB Biogen Inc | 1.60 mm | 6.20 k shares | 1.16 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 1.54 mm | 1.75 k shares | 1.11 | Common equity | Long | USA |
LH Laboratory Corp. Of America Holdings | 1.46 mm | 6.44 k shares | 1.06 | Common equity | Long | USA |
PODD Insulet Corporation | 1.33 mm | 6.11 k shares | 0.96 | Common equity | Long | USA |
ILMN Illumina Inc | 1.29 mm | 9.24 k shares | 0.93 | Common equity | Long | USA |
Chugai Pharmaceutical Co Ltd
|
1.21 mm | 31.90 k shares | 0.87 | Common equity | Long | Japan |
EHC Encompass Health Corp | 1.19 mm | 17.77 k shares | 0.85 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 1.16 mm | 4.76 k shares | 0.84 | Common equity | Long | USA |
HOLX Hologic, Inc. | 1.08 mm | 15.10 k shares | 0.78 | Common equity | Long | USA |
Eisai Co Ltd
|
1.07 mm | 21.41 k shares | 0.77 | Common equity | Long | Japan |
ARGX Argen X SE | 1.06 mm | 2.79 k shares | 0.76 | Common equity | Long | Netherlands |
Novartis AG
|
1.04 mm | 10.33 k shares | 0.75 | Common equity | Long | Switzerland |
WAT Waters Corp. | 1.03 mm | 3.12 k shares | 0.74 | Common equity | Long | USA |
ACHC Acadia Healthcare Company Inc | 1.03 mm | 13.19 k shares | 0.74 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 983.51 k | 11.78 k shares | 0.71 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 907.27 k | 4.13 k shares | 0.65 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 898.10 k | 4.69 k shares | 0.65 | Common equity | Long | USA |
RGEN Repligen Corp. | 875.63 k | 4.87 k shares | 0.63 | Common equity | Long | USA |
EVH Evolent Health Inc - Ordinary Shares | 863.73 k | 26.15 k shares | 0.62 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 861.43 k | 57.81 k shares | 0.62 | Common equity | Long | USA |
TFX Teleflex Incorporated | 785.92 k | 3.15 k shares | 0.57 | Common equity | Long | USA |
GSK PLC
|
771.75 k | 41.79 k shares | 0.56 | Common equity | Long | UK |
GILD Gilead Sciences, Inc. | 770.41 k | 9.51 k shares | 0.56 | Common equity | Long | USA |
SGRY Surgery Partners Inc | 760.59 k | 23.78 k shares | 0.55 | Common equity | Long | USA |
OPCH Option Care Health Inc. - Registered Shares | 750.28 k | 22.27 k shares | 0.54 | Common equity | Long | USA |
ADUS Addus HomeCare Corporation | 741.31 k | 7.98 k shares | 0.53 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 722.78 k | 9.77 k shares | 0.52 | Common equity | Long | USA |
ABMD Abiomed Inc | 707.74 k | 3.71 k shares | 0.51 | Common equity | Long | USA |
Otsuka Holdings Co Ltd
|
673.15 k | 18.00 k shares | 0.49 | Common equity | Long | Japan |
UCB SA
|
658.15 k | 7.55 k shares | 0.47 | Common equity | Long | Belgium |
KRTX Karuna Therapeutics Inc | 648.85 k | 2.05 k shares | 0.47 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 643.48 k | 5.11 k shares | 0.46 | Common equity | Long | Denmark |
APLS Apellis Pharmaceuticals Inc | 632.24 k | 10.56 k shares | 0.46 | Common equity | Long | USA |
VLTO Veralto Corp | 630.28 k | 7.66 k shares | 0.45 | Common equity | Long | USA |
NARI Inari Medical Inc | 621.67 k | 9.58 k shares | 0.45 | Common equity | Long | USA |
Alkermes PLC
|
614.27 k | 22.14 k shares | 0.44 | Common equity | Long | Ireland |
Immunocore Holdings PLC
|
594.18 k | 8.70 k shares | 0.43 | Common equity | Long | UK |
RVMD Revolution Medicines Inc | 591.67 k | 20.63 k shares | 0.43 | Common equity | Long | USA |
DiaSorin SpA
|
578.91 k | 5.62 k shares | 0.42 | Common equity | Long | Italy |
CLDX Celldex Therapeutics Inc. | 565.19 k | 14.25 k shares | 0.41 | Common equity | Long | USA |
AVTR Avantor Inc. | 561.25 k | 24.58 k shares | 0.40 | Common equity | Long | USA |
Genmab A/S
|
557.99 k | 1.75 k shares | 0.40 | Common equity | Long | Denmark |
Tecan Group AG
|
549.84 k | 1.34 k shares | 0.40 | Common equity | Long | Switzerland |
AGL Agilon Health Inc | 541.56 k | 43.15 k shares | 0.39 | Common equity | Long | USA |
VCYT Veracyte Inc | 533.67 k | 19.40 k shares | 0.38 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 522.54 k | 12.82 k shares | 0.38 | Common equity | Long | Cayman Islands |
TECH Bio-Techne Corp | 518.21 k | 6.72 k shares | 0.37 | Common equity | Long | USA |
PRVA Privia Health Group Inc | 496.64 k | 21.57 k shares | 0.36 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 485.63 k | 24.43 k shares | 0.35 | Common equity | Long | UK |
CRNX Crinetics Pharmaceuticals Inc | 473.75 k | 13.32 k shares | 0.34 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 458.62 k | 4.97 k shares | 0.33 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 456.40 k | 4.73 k shares | 0.33 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 453.10 k | 7.22 k shares | 0.33 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 452.08 k | 9.82 k shares | 0.33 | Common equity | Long | Canada |
Merus NV
|
427.49 k | 15.55 k shares | 0.31 | Common equity | Long | Netherlands |
BBIO BridgeBio Pharma Inc | 426.11 k | 10.56 k shares | 0.31 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 419.43 k | 14.00 k shares | 0.30 | Common equity | Long | USA |
MRNA Moderna Inc | 406.85 k | 4.09 k shares | 0.29 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 395.90 k | 18.32 k shares | 0.29 | Common equity | Long | USA |
Genus PLC
|
376.51 k | 13.61 k shares | 0.27 | Common equity | Long | UK |
RARE Ultragenyx Pharmaceutical Inc. | 368.98 k | 7.72 k shares | 0.27 | Common equity | Long | USA |
FIXED INC CLEARING CORP.REPO
Fixed Income Clearing Corp
|
345.84 k | 345.84 k principal | 0.25 | Repurchase agreement | Long | USA |
LEGN Legend Biotech Corp | 336.23 k | 5.59 k shares | 0.24 | Common equity | Long | Cayman Islands |
Zai Lab Ltd
|
329.96 k | 12.07 k shares | 0.24 | Common equity | Long | Cayman Islands |
QDEL QuidelOrtho Corp | 328.85 k | 4.46 k shares | 0.24 | Common equity | Long | USA |
HSBC U.S. Government Money Market Fund | 315.71 k | 315.71 k shares | 0.23 | Short-term investment vehicle | Long | USA |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
|
307.96 k | 23.40 k shares | 0.22 | Common equity | Long | China |
Hapvida Participacoes e Investimentos S/A
|
299.46 k | 327.14 k shares | 0.22 | Common equity | Long | Brazil |
Roivant Sciences Ltd
|
277.09 k | 24.67 k shares | 0.20 | Common equity | Long | Bermuda |
PTCT PTC Therapeutics Inc | 244.82 k | 8.88 k shares | 0.18 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 239.03 k | 1.18 k shares | 0.17 | Common equity | Long | USA |
MORF Morphic Holding Inc | 198.75 k | 6.88 k shares | 0.14 | Common equity | Long | USA |
GH Guardant Health Inc | 196.03 k | 7.25 k shares | 0.14 | Common equity | Long | USA |
Prothena Corp PLC
|
177.38 k | 4.88 k shares | 0.13 | Common equity | Long | Ireland |
SAGE Sage Therapeutics Inc | 174.53 k | 8.05 k shares | 0.13 | Common equity | Long | USA |
Smith & Nephew PLC
|
101.89 k | 7.42 k shares | 0.07 | Common equity | Long | UK |
Goldman Sachs Financial Square Funds - Government Fund | 94.71 k | 94.71 k shares | 0.07 | Short-term investment vehicle | Long | USA |
Invesco Government & Agency Portfolio | 94.71 k | 94.71 k shares | 0.07 | Short-term investment vehicle | Long | USA |
Morgan Stanley Institutional Liquidity Funds - Government Portfolio | 94.71 k | 94.71 k shares | 0.07 | Short-term investment vehicle | Long | USA |
CITIBANK NA DDCA | 31.57 k | 31.57 k shares | 0.02 | Short-term investment vehicle | Long | USA |
CONTRA ABIOMED INC | 902.70 | 885.00 shares | 0.00 | Equity derivative | N/A | USA |